Inventor · disambiguated record
Roy A. Swaringen, Jr.
Also filed as: SWARINGEN JR ROY · SWARINGEN JR ROY A · SWARINGEN JR ROY ARCHIBALD · SWARINGEN ROY
21 granted patents·5 pending applications·229 citations·filing 1977–2022
95Inventor score
Files withKYTHERA BIOPHARMACEUTICALS INC8BURROUGHS WELLCOME CO7ALLERGAN SALES LLC4GLAXO WELLCOME INC2HEMP CHRISTIAN2
Top patents by PatentIndex Score
26 records- 0197US7902387B2Preparation of bile acids and intermediates thereofKYTHERA BIOPHARMACEUTICALS INC·Filed 2008·Granted Mar 8, 2011·31 cites·15 claims
- 0295US8367852B2Preparation of bile acids and intermediates thereofKYTHERA BIOPHARMACEUTICALS INC·Filed 2011·Granted Feb 5, 2013·11 cites·1 claims
- 0393US8362285B2Preparation of bile acids and intermediates thereofKYTHERA BIOPHARMACEUTICALS INC·Filed 2011·Granted Jan 29, 2013·7 cites·11 claims
- 0492US7994351B2Preparation of bile acids and intermediates thereofKYTHERA BIOPHARMACEUTICALS INC·Filed 2009·Granted Aug 9, 2011·8 cites·9 claims
- 0588US4491665AMethod of preparing isomers of bis isoquinolinium compoundsBURROUGHS WELLCOME CO·Filed 1981·Granted Jan 1, 1985·23 cites·1 claims
- 0686US9150607B2Preparation of bile acids and intermediates thereofKYTHERA BIOPHARMACEUTICALS INC·Filed 2012·Granted Oct 6, 2015·2 cites·5 claims
- 0786US4761418ANovel compoundsBURROUGHS WELLCOME CO·Filed 1985·Granted Aug 2, 1988·47 cites·15 claims
- 0886US4701460ALong duration neuromuscular blocking agentsBURROUGHS WELLCOME CO·Filed 1985·Granted Oct 20, 1987·24 cites·12 claims
- 0986US4144263ABenzyl cyanoacetalsBURROUGHS WELLCOME CO·Filed 1977·Granted Mar 13, 1979·12 cites·14 claims
- 1081US4216319ASynthesis of 2,4-diamino-5-benzylpyrimidines using benzyl cyanoacetal intermediatesBURROUGHS WELLCOME CO·Filed 1978·Granted Aug 5, 1980·11 cites·19 claims
- 1177US10981946B2Methods for the purification of deoxycholic acidALLERGAN SALES LLC·Filed 2019·Granted Apr 20, 2021·0 cites·10 claims
- 1276US10633412B2Preparation of bile acids and intermediates thereofALLERGAN SALES LLC·Filed 2018·Granted Apr 28, 2020·0 cites·16 claims
- 1374US11008363B2Preparation of bile acids and intermediates thereofALLERGAN SALES LLC·Filed 2020·Granted May 18, 2021·0 cites·10 claims
- 1474US9683007B2Methods for the purification of deoxycholic acidKYTHERA BIOPHARMACEUTICALS INC·Filed 2014·Granted Jun 20, 2017·1 cites·4 claims
- 1569US2024317783A1Processes of preparing psilocin and psilocybinTERRAN BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1668US6187789B1Substituted isoquinolines as ultra short acting neuromuscular blockersGLAXO WELLCOME INC·Filed 1998·Granted Feb 13, 2001·23 cites·7 claims
- 1767US10053486B2Preparation of bile acids and intermediates thereofKYTHERA BIOPHARMACEUTICALS INC·Filed 2015·Granted Aug 21, 2018·0 cites·4 claims
- 1866US10472384B2Methods for the purification of deoxycholic acidALLERGAN SALES LLC·Filed 2018·Granted Nov 12, 2019·0 cites·8 claims
- 1966US4500711ASynthesis of leucovorinBURROUGHS WELLCOME CO·Filed 1980·Granted Feb 19, 1985·7 cites·8 claims
- 2065US6177445B1Substituted isoquinolines as ultra short acting neuromuscular blockersGLAXO WELLCOME INC·Filed 1998·Granted Jan 23, 2001·21 cites·16 claims
- 2165US2013267721A1Preparation of bile acids and intermediates thereofPRASAD ACHAMPETA RATHAN·Filed 2013·Application pending·0 cites
- 2263US10005813B2Methods for the purification of deoxycholic acidKYTHERA BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·0 cites·12 claims
- 2355US2013137884A1Methods for the purification of deoxycholic acidMORIARTY ROBERT M·Filed 2010·Application pending·0 cites
- 2450US2011313191A1Preparation of Pharmaceutical Salts of 3-0-(3',3'-Dimethylsuccinyl) Betulinic AcidHEMP CHRISTIAN·Filed 2011·Application pending·0 cites
- 2549US2007203103A1Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acidHEMP CHRISTIAN·Filed 2006·Application pending·0 cites
- 2642US4568744ABenzylpyrimidine synthesis and intermediatesBURROUGHS WELLCOME CO·Filed 1984·Granted Feb 4, 1986·1 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →